iShares Neuroscience and Healthcare ETF (IBRN) Price & Chart
IBRN ETF Chart & Stats
- Day’s Range
- $31.51 - $31.76
- 52-Week Range
- $27.70 - $43.01
- Previous Close
- $31.84
- Volume
- 1,096
- Average Volume (3M)
- 2,445
- AUM
- 6.37M
- NAV
- 31.52
- Expense Ratio
- 0.47%
- Holdings Count
- 69
- Beta
- 1.12
- Inception Date
- Aug 24, 2022
- Last Dividend Ex-Date
- Dec 16, 2025
- Dividend Yield
- (1.01%)
- Shares Outstanding
- 200,000
- Standard Deviation
- N/A
ETF Overview
iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an innovative investment vehicle designed for those looking to capitalize on the dynamic and rapidly evolving field of health care, with a specialized focus on the neuroscience and life sciences sectors. This ETF offers investors targeted exposure to companies at the forefront of pharmaceutical, biotechnology, and life sciences advancements, particularly those spearheading breakthroughs in neurological research and treatments. As a sector-focused fund, IBRN stands out for its commitment to capturing growth within the pharma, biotech, and life sciences niche, offering a diversified portfolio of firms that are pioneering in medical innovation and technology. Investors in IBRN gain access to a carefully curated selection of enterprises that are not only shaping the future of health care but are also poised to benefit from the increasing global demand for advanced neurological solutions and therapies. With its emphasis on cutting-edge research and development, the iShares Neuroscience and Healthcare ETF represents a compelling opportunity for investors seeking to align their portfolios with the next wave of health care transformation.
iShares Neuroscience and Healthcare ETF (IBRN) Fund Flow Chart
IBRN ETF FAQ
What was IBRN’s price range in the past 12 months?
What is the AUM of IBRN?
Is IBRN overvalued?
Does IBRN pay dividends?
How many shares outstanding does IBRN have?
IBRN ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| BIIBBiogen Inc. | 5.33% |
| ALKSAlkermes plc | 4.63% |
| EWTXEdgewise Therapeutics, Inc. | 4.46% |
| NBIXNeurocrine Biosciences | 4.42% |
| PTCTPTC Therapeutics | 4.40% |
| ARGXArgenx | 4.09% |
| PRAXPraxis Precision Medicines, Inc. | 3.64% |
| SRRKScholar Rock Holding | 3.62% |
| ACADACADIA Pharmaceuticals Inc. | 3.53% |
| DNTHDianthus Therapeutics, Inc. | 3.52% |
| Total | 41.64% |